LONDON, 10 November 2026 — Kantesti Ltd announced in London on 10 November 2026 that its V12 engine now explains HIV test results from uploaded laboratory reports, helping people understand the paperwork before speaking with their doctor. The first report is free.
HIV test results on a laboratory report are explained in context
Kantesti V12 reads the report a laboratory issued, whether uploaded as a PDF or a photo. It explains which HIV tests appear on that report, how the laboratory describes their results and which questions a person may wish to take to a clinician. The service is intended for anyone who wants to understand an HIV lab report before that conversation.
For fourth-generation HIV-1/2 antigen/antibody tests, the explanation covers HIV-1/2 antibodies and p24 antigen. It describes “reactive” and “non-reactive” as laboratory terms and explains that a reactive screening result is not, by itself, a diagnosis.
Where the report includes supplementary antibody differentiation or HIV RNA tests, V12 explains how those confirmatory tests relate to the screening result. It works from tests the laboratory has already performed and printed on the report; it does not perform a test or determine a person's HIV status.
“An HIV test report is one of the most stressful pieces of paper a person can hold, and nobody should have to decode it alone. We do not diagnose. We help people find their way through the report and to the right next step: their doctor.”
Viral load, CD4 count and test timing are covered
The explanation also covers viral load, reported as HIV RNA in copies/mL, and CD4 count, reported in cells/µL, when those measurements appear on the report. It describes what each measurement represents and what the laboratory term “undetectable” refers to, without providing medical advice about an individual result.
V12 addresses the window period: a test taken very soon after a possible exposure can be negative and may need repeating, as the laboratory or clinician advises. It then provides a short list of questions to take to a doctor or sexual health clinic rather than advising a person on their care.
Early testing leads to early treatment, and the source document states that a person on effective treatment whose viral load stays undetectable does not pass HIV on through sex. It describes HIV as a manageable long-term condition when found and treated. These points provide general context, not an assessment of any uploaded report.
“These explanations are educational. A reactive screening result needs confirmatory testing, and a person's own doctor or sexual health clinic should assess results and advise on next steps. Anyone concerned about a possible exposure should seek professional help without delay.”
Reports can be uploaded online or through the app
A person can upload the report at www.kantesti.net or through the Kantesti app for iOS and Android. Accepted formats are PDF, JPG, PNG, HEIC and WEBP. After choosing a language, the person can read the plain-language explanation; Kantesti Voice can also read the summary aloud.
The service provides the explanation in under 60 seconds from upload and supports 100+ languages. The first report is free.
The workflow is based on the laboratory-issued document, not on an estimate from other blood values. A routine blood count or biochemistry panel cannot establish whether someone has HIV; only an HIV test can address that question. The service explains existing report terminology for discussion with a qualified professional.
The announcement follows reporting about HIV in Russia
The timing follows recent media coverage of HIV in Russia. CNN Türk reported that an outbreak had spread to 27 regions and that cases of transmission in hospitals had reached a record level. Kantesti has no connection with the events in that report.
Such coverage can lead people to seek laboratory testing for the first time and then confront unfamiliar wording in the resulting paperwork. Kantesti's announcement addresses that point in the process: after a laboratory has issued a report and before the person discusses it with a doctor or sexual health clinic.
A reactive screening result requires a confirmatory test before any diagnosis is made. Understanding the distinction can help a person identify what to ask next, but an AI-generated explanation cannot supply the follow-up test, counselling or clinical assessment.
Educational information does not replace clinical care
Kantesti provides AI-assisted informational and educational support only. It is not a medical device and is not CE- or UKCA-marked. It does not diagnose, screen for or rule out HIV, and it is not intended to monitor, predict, treat, cure or prevent HIV or any other disease.
The service does not provide medical advice or replace testing, counselling, a doctor's assessment or treatment. People should consult a qualified healthcare professional about their results and before making medical decisions. The suggested questions are intended to support that conversation, not settle it.
Anyone who thinks they may have been exposed to HIV should contact a doctor, sexual health clinic or local testing service without delay. Preventive treatment after exposure is time-critical; uploading a report is not a substitute for seeking that help.
Source document
Kantesti V12 Understands HIV Test Results: Free AI Blood Test Analyzer Explains HIV Lab Reports Online, in 100+ Languages
The attached PDF describes the HIV test terms Kantesti V12 explains, the upload process, availability and the limits of the service, including its safety information and the cited news context.
Frequently asked questions
Can Kantesti tell someone whether they have HIV?
No. Kantesti explains HIV tests that a laboratory has already performed and included on an uploaded report. It does not diagnose, screen for or rule out HIV. A routine blood count or biochemistry panel cannot establish HIV status, and the service does not replace testing, counselling or assessment by a doctor.
Which results does V12 explain on an HIV lab report?
Where present on the report, V12 explains fourth-generation HIV-1/2 antigen/antibody screening terms, supplementary antibody differentiation and HIV RNA confirmatory tests, viral load and CD4 count. It also covers the window period and provides questions for a doctor or sexual health clinic. A reactive screening result is not, by itself, a diagnosis.
How can someone access the explanation, and what does it cost?
The laboratory-issued report can be uploaded at www.kantesti.net or in the Kantesti app for iOS and Android as a PDF, JPG, PNG, HEIC or WEBP file. After choosing a language, the person can read the explanation or listen to its summary with Kantesti Voice. The first report is free.
What should someone do after a possible HIV exposure?
Contact a doctor, sexual health clinic or local testing service without delay because preventive treatment after exposure is time-critical. A test taken very soon after exposure can be negative and may need repeating as the laboratory or clinician advises. Kantesti's explanation cannot replace that advice or testing.
Notes to editors
- Kantesti Ltd is a UK-registered health technology company (Companies House No. 17090423) that turns laboratory results into clear, AI-assisted explanations for more than 2 million users. Its platform accepts blood-test PDFs and photos in more than 100 languages and offers tools such as a biological blood age, a body map, comparison and trend analysis, nutrition plans, DNA-based health reports and Kantesti Voice for individuals and clinics.
- The press office can be reached at [email protected]; the website is www.kantesti.net.
- The first report is free. Reports can be uploaded through the website or the Kantesti app for iOS and Android in PDF, JPG, PNG, HEIC or WEBP format.
- Kantesti Voice can read the summary aloud. The explanation is available in 100+ languages.
- The PDF's illustrations and sample report are for orientation only; the sample report contains no patient data.
- The news item cited in the PDF is CNN Türk, “Rusya’da 27 bölgeye yayılan HIV salgını: Hastanelerde bulaşma vakaları rekor seviyede” (cnnturk.com). Kantesti has no connection with the events reported.
- Kantesti supplies educational information only. It is not a medical device, is not CE- or UKCA-marked and does not provide medical advice.
About Kantesti
Kantesti Ltd is a UK-registered health technology company (Companies House No. 17090423) that turns laboratory results into clear, AI-assisted explanations for more than 2 million users. Its platform interprets blood tests uploaded as PDFs or photos in more than 100 languages and adds tools such as a biological blood age, a body map, comparison and trend analysis, nutrition plans, DNA-based health reports and Kantesti Voice, for individuals and clinics.
Kantesti Ltd · Companies House No. 17090423 · 4 Raven Road, Unit 1c3-1100, London E18 1HB, United Kingdom
Media contact
Kantesti Ltd — Press Office
[email protected]
+44 7508 364740
www.kantesti.net
Media assets
People
Written by
Julian Emirhan Bulut
Founder & CEO, Kantesti Ltd
Julian Emirhan Bulut is the founder and Chief Executive Officer of Kantesti Ltd. A medical AI specialist educated at the University of Milan, he leads the design of the Kantesti AI blood test analyzer, its neural-network interpretation engine and its multilingual reporting, and is accountable for every product announcement the company makes.
Reviewed by
Thomas Klein, MD
Chief Medical Officer (CMO), Kantesti Ltd
Dr. Thomas Klein is a board-certified clinical hematologist and internist with over 15 years of experience in laboratory medicine and AI-assisted clinical analysis. As Chief Medical Officer at Kantesti, he provides clinical oversight of the medical accuracy of the platform and reviews clinical statements in Kantesti publications.
